Diabetic AMI patients receive suboptimal thrombolytic treatment
Main Authors: | Lyford Joanna, Gustafsson I, Hildebrandt P, Seibaek M, Melchior T, Torp-Pedersen C, Kober L, Kaiser-Nielsen P |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2001-01-01
|
Series: | Current Controlled Trials in Cardiovascular Medicine |
Subjects: | |
Online Access: | http://cvm.controlled-trials.com/paperreport/cvm-2001-72161 |
Similar Items
-
Ischemic stroke complicating thrombolytic therapy with tenecteplase for ST elevation myocardial infarction: two case reports
by: Salim Arous, et al.
Published: (2017-06-01) -
Reasons for not receiving thrombolytic therapy in patients with acute myocardial infarction admitted to Bu-Ali Sina Hospital in Qazvin (2013-14)
by: MM. Daei, et al.
Published: (2017-04-01) -
A study on clinical profile and in-hospital outcome of elderly patients receiving thrombolytic therapy for ST elevation myocardial infarction
by: Darshan P Thakkar, et al.
Published: (2022-01-01) -
A case of sudden-onset painless unilateral vision loss postintravenous streptokinase in a patient of acute inferior-wall myocardial infarction
by: Monika Bhandari, et al.
Published: (2018-01-01) -
CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01)